Mineralys Therapeutics, Inc. (MLYS)
(Delayed Data from NSDQ)
$13.06 USD
+0.13 (1.01%)
Updated May 14, 2024 04:00 PM ET
After-Market: $13.05 -0.01 (-0.08%) 7:28 PM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.77 | 0.00% |
Earnings Summary
For their last quarter, Mineralys Therapeutics, Inc. (MLYS) reported earnings of -$0.70 per share, missing the Zacks Consensus Estimate of -$0.68 per share. This reflects a negative earnings surprise of 2.94%. Look out for MLYS's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.77 per share, reflecting a year-over-year decrease of 148.39%.
Earnings History
Price & Consensus
Zacks News for MLYS
Wall Street Analysts See a 199.3% Upside in Mineralys Therapeutics, Inc. (MLYS): Can the Stock Really Move This High?
MLYS: What are Zacks experts saying now?
Zacks Private Portfolio Services